Oissel, France

J Er Guillemont

This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: J Er Guillemont. Retrieved from https://idiyas.com/inventor/j-er-guillemont

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: J Er Guillemont: Innovator in Pharmaceutical Chemistry

Introduction

J Er Guillemont is a notable inventor based in Oissel, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on 4-quinolinyl derivatives. His expertise and dedication to research have led to the development of valuable patents that enhance the pharmaceutical landscape.

Latest Patents

J Er Guillemont holds a patent for 4-quinolinyl derivatives. This patent represents a crucial advancement in the development of new therapeutic agents, showcasing his ability to innovate within the pharmaceutical sector. His work is instrumental in addressing various medical needs through chemical innovation.

Career Highlights

Guillemont is associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His role at Janssen has allowed him to collaborate with other talented professionals and contribute to groundbreaking research and development projects. His career is marked by a commitment to improving healthcare through innovative solutions.

Collaborations

Throughout his career, J Er Guillemont has worked alongside esteemed colleagues such as Marc Gaston Venet and Daniel F Vernier. These collaborations have fostered a dynamic environment for creativity and innovation, leading to significant advancements in their respective fields.

Conclusion

J Er Guillemont's contributions to pharmaceutical chemistry through his patent on 4-quinolinyl derivatives exemplify his dedication to innovation. His work at Janssen Pharmaceutica NV and collaborations with other professionals highlight his impact on the industry. His achievements continue to inspire future advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…